Spire reshapes leadership around £1.03bn takeover

Spire reshapes leadership around £1.03bn takeover

Spire is changing leadership as its private takeover moves forward. Justin Ash is retiring as chief executive, with Sir David Sloman becoming interim CEO as Tulip UK Bidco prepares to take ownership.


Spire Healthcare is reshaping its senior leadership as the private hospital group prepares to move into new ownership following a £1.03bn takeover agreement.

Chief executive Justin Ash will retire, with vice-chair and non-executive director Sir David Sloman becoming interim chief executive while the company searches for a permanent successor. The management change comes as Spire prepares for ownership by Tulip UK Bidco, the acquisition vehicle backed by Toscafund, THCP Advisory, and Ares.

The agreed offer values Spire at 250p a share and follows a strategic review and months of discussions over the future ownership of one of Britain’s largest independent healthcare groups.

Debbie White, Spire’s chair-designate, said: “On behalf of the Board, I would like to thank Justin for his many years of service to the company.”

Sir David brings extensive public-healthcare management experience. He joined Spire as a non-executive director in March 2025, became vice-chair two months later, and previously held chief executive roles across NHS trusts before serving as chief operating officer of NHS England between December 2021 and August 2023.

The transition comes as private healthcare providers continue to operate alongside severe capacity pressure in the NHS. Spire treated more than 1.36 million people in 2025 across its hospital and primary-care operations and generated group revenue of £1.58bn, up 4.5% from the previous year.

Adjusted EBITDA reached £268.6m in 2025, while primary-care revenue rose 10.5% to £133.7m. The group has been expanding beyond its traditional hospital network while seeking greater use of existing facilities and tighter control over operating costs.

Healthcare assets attract long-term capital because demand is relatively resilient and established hospital estates are difficult to replicate. They also require substantial investment. Clinical governance, specialist staffing, equipment, digital systems, property maintenance, and regulatory compliance create costs that cannot be reduced without affecting operating capacity or standards.

The takeover also sits within a wider shift in London’s public markets. A succession of takeovers has continued to reduce the number of quoted UK companies, feeding debate over valuations, liquidity, new listings, and whether some businesses can obtain a higher value under private ownership.

Spire’s transaction illustrates that tension. The buyer group is acquiring an established healthcare platform with revenue growth, physical assets, and exposure to rising private demand, while existing shareholders are being offered a cash exit at an agreed premium.

Private ownership will not change the clinical or regulatory obligations attached to the business. Spire will continue to operate in a healthcare system facing workforce constraints, wage pressure, complex regulation, and sustained demand for treatment. Its relationships with insurers, self-pay patients, clinicians, and the NHS will remain central to performance.

Leadership continuity is therefore an important part of the transaction. Ash has led Spire since 2017 and spans much of the group’s recent strategic development. Sir David’s appointment puts an executive with substantial healthcare operating experience into the interim role while the search for a permanent chief executive proceeds.

The incoming management team will inherit a business whose growth increasingly spans both hospital care and primary services. That broadening model places more emphasis on integration, referral pathways, technology, utilisation, and the ability to manage different healthcare settings within a single group.

New ownership also changes the governance structure around those decisions. Listed companies operate within public-market disclosure, shareholder voting, remuneration, and reporting requirements that differ from the arrangements applying to privately held businesses. The commercial and clinical fundamentals, however, remain the same.

The combination of a takeover, chief executive transition, and wider board change means Spire is entering its next ownership phase with substantial governance change already under way. The search for a permanent chief executive will be one of the earliest decisions shaping how the new owners approach investment, operational efficiency, and growth across the group.



  • Spire reshapes leadership around £1.03bn takeover

    Spire reshapes leadership around £1.03bn takeover

    Spire is changing leadership as its private takeover moves forward. Justin Ash is retiring as chief executive, with Sir David Sloman becoming interim CEO as Tulip UK Bidco prepares to take ownership.


  • EDF eyes So Energy customers in consolidation push

    EDF eyes So Energy customers in consolidation push

    EDF is pursuing So Energy customers amid market consolidation talks. Discussions could add roughly 300,000 household customers to EDF, although no transaction has been agreed and other bidders remain in contention.


  • Castore explores sale after takeover approaches

    Castore explores sale after takeover approaches

    Castore is exploring strategic options after receiving multiple takeover approaches. The sportswear group has appointed JPMorgan, with possible outcomes ranging from minority investment or partnership to a full sale or no transaction.